The medtech company of the future will likely operate in a dramatically altered healthcare landscape. Forward-thinking medtechs are evolving into six winning roles that will enable them to strengthen core capabilities, expand offerings, and enter new spaces to create value and thrive in tomorrow’s consumer-centric, digitally powered marketplace. By Pedro Arboleda, and Jay Zhu, Deloitte Consulting LLP.
Welcome to MyStrategist, an online experience like no other in the medical device industry.
With MyStrategist, quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and MedTech Strategist Market Pathways – now on an all-in-one, digital platform. We invite you to explore our coverage.
Think Strategically. Subscribe Today.
Deloitte: Medtech’s Business Imperative; Accelerate the Deployment of Virtual Health Capabilities to Help Navigate Near-term Needs and Thrive in a Post-COVID-19 World
Deloitte: Embracing Virtual Health to Help Medtech Companies Thrive
Deloitte: The Post-COVID-19 Shutdown Rebound: How Medtech Companies Can Help Support Deferred Care and Procedure Recovery
Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market PathwaysStart Trial
Docbot offers real-time AI during conventional colorectal screening by colonoscopy. Today it’s validating the software’s potential to boost adenoma detection rates; in the near future, it will offer a tool for real-time polyp characterization.
Will COVID-19 Permanently Alter the Surgical Products Market? A Conversation with Tom O’Brien, Ethicon Endomechanical
LifeSignals Group: Single-chip Wearable Biosensor and a B2B Approach
Medtronic’s Companion Medical Acquisition: Exploring the Impetus with MDT's Mike Hill
Virtual Investment & Partnering Summit 2020 registration is now open. On-Demand October 15th – November 20th this year's most anticipated global event will sell out. Register Today!Register Learn More
Viz.ai’s ContaCT system is the first AI software to nab a Medicare inpatient new-technology add-on payment, but it took some convincing of CMS and the agency is not making any promises about its approach to future AI offerings.